DUBLIN–(BUSINESS WIRE)–The “Carbapenem Antibiotics Market Forecast to 2028 – Impact of COVID-19 and Global Analysis by Type, Indication and Distribution Channel” report has been added to from ResearchAndMarkets.com offer.
The carbapenem antibiotics market size is expected to reach US$5,346.62 million by 2028 from US$3,964.57 million in 2021; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.
Generic versions of antibiotics are popular due to their availability and affordability. Additionally, the expiration of patented carbapenem antibiotics has expanded the opportunities for generic drug manufacturers to enter the market with their profitable drugs. The goal of generic drug producers is to increase the reach of these drugs. Moreover, the shortage of antibiotics to treat bacterial infections is also one of the major drivers for the growth of the market. The increase in the production of generic carbapenem antibiotics has expanded the availability of the drugs in various low- and middle-income countries.
Based on type, the carbapenem antibiotics market is segmented into meropenem, doripenem, imipenem, tebipenem and others. The others segment held the largest market share of the carbapenem antibiotics market in 2021, and it is expected to register the highest CAGR in the carbapenem antibiotics market during the forecast period. The growing developments of carbapenem antibiotics are expected to drive the market growth in the future.
Based on indications, the carbapenem antibiotics market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, intra-abdominal infections, urinary tract infections and others. The others segment held the largest carbapenem antibiotics market share in 2021 and is estimated to register the highest CAGR in the market during the forecast period.
By distribution channel, the carbapenem antibiotics market is segmented into retail pharmacies, online pharmacies and hospital pharmacies. The hospital pharmacy segment held the largest carbapenem antibiotics market share in 2021, and is estimated to register the highest CAGR in the market during the forecast period.
Based on geography, the carbapenem antibiotics market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America dominates the global market share and is expected to maintain its strong position in the coming years.
The region is expected to experience steady growth in the future due to factors such as increased adoption of carbapenem antibiotics, high rate of antibiotic prescribing, and progress in research and development leading to the emergence and launch of new drugs.
However, the Asia-Pacific market is expected to witness the fastest growth in the coming years. The market size of carbapenem antibiotics in India and China is expected to grow rapidly due to factors such as large population, growing interest of market players in developing new vaccines and products at affordable prices, and the high penetration of market players manufacturing generic drugs and exporting them across the world.
Main topics covered:
1.1 Scope of the study
1.2 Guidelines for the research report
1.3 Market Segmentation
1.3.1 Global Carbapenem Antibiotics Market – By Type
1.3.2 Global Carbapenem Antibiotics Market – By Indication
1.3.3 Global Carbapenem Antibiotics Market – By Distribution Channel
1.3.4 Global Carbapenem Antibiotics Market – By Geography
2. Carbapenem Antibiotics Market – Key Takeaways
3. Research methodology
4. Global Carbapenem Antibiotics Market – Market Landscape
5. Carbapenem Antibiotics Market – Key Market Dynamics
5.1.1 Increasing prevalence of Gram-negative bacterial infections
5.1.2 Increase in the production of generic drugs
5.2 Market Constraints
5.2.1 Time-consuming and expensive antibiotic development process
5.3 Market Opportunities
5.3.1 Private and public partnerships
5.4 Future trends
5.4.1 Strategic advancement for the identification of new antibiotics
5.5 Impact analysis
6. Carbapenem Antibiotics Market – Global Analysis
6.1 Global Carbapenem Antibiotics Market Revenue Forecast and Analysis
6.2 Global Carbapenem Antibiotics Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Carbapenem Antibiotics Market Analysis – By Type
8. Carbapenem Antibiotics Market – By Indication
9. Carbapenem Antibiotics Market – By Distribution Channel
10. Carbapenem Antibiotics Market – Regional Analysis
11. Impact of COVID-19 Pandemic on the Global Carbapenem Antibiotics Market
12. Carbapenem Antibiotics Market and Industry Landscape
Sumitomo Dainippon Pharma
Merck & Co., Inc.
Gland Pharma Limited
Aurobindo Pharma Ltd
Iterum Therapeutics plc
ACS Dobfar SpA
For more information on this report, visit https://www.researchandmarkets.com/r/i4v7vt
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.